Jaros MJ - Search Results

1

Impact of Data Imputation Methodology on Pain Assessment over 24 Hours in a Randomized, Placebo-Controlled Study of Gabapentin Enacarbil in Patients with Neuropathic Pain Associated with Postherpetic Neuralgia.

Calkins AM, Gudin J, Gidal B, Jaros MJ, Kim R, Shang G. Calkins AM, et al. Among authors: jaros mj. Pain Med. 2016 Apr;17(4):728-36. doi: 10.1093/pm/pnv072. Epub 2016 Jan 6. Pain Med. 2016. PMID: 26814307 Clinical Trial.

2

Treatment response to sleep, pain, and mood disturbance and their correlation with sleep disturbance in adult patients with moderate-to-severe primary restless legs syndrome: Pooled analyses from 3 trials of gabapentin enacarbil.

Bogan RK, Lee DO, Buchfuhrer MJ, Jaros MJ, Kim R, Shang G. Bogan RK, et al. Among authors: jaros mj. Ann Med. 2015 May;47(3):269-77. doi: 10.3109/07853890.2015.1025825. Epub 2015 Apr 15. Ann Med. 2015. PMID: 25874578 Clinical Trial.

3

Effect of prior exposure to dopamine agonists on treatment with gabapentin enacarbil in adults with moderate-to-severe primary restless legs syndrome: pooled analyses from 3 randomized trials.

Ondo WG, Hermanowicz N, Borreguero DG, Jaros MJ, Kim R, Shang G. Ondo WG, et al. Among authors: jaros mj. J Clin Mov Disord. 2015 Mar 30;2:9. doi: 10.1186/s40734-015-0018-3. eCollection 2015. J Clin Mov Disord. 2015. PMID: 26788345 Free PMC article.

4

The Effect of Gabapentin Enacarbil on Quality of Life and Mood Outcomes in a Pooled Population of Adult Patients with Moderate-to-Severe Primary Restless Legs Syndrome.

Avidan AY, Lee D, Park M, Jaros MJ, Shang G, Kim R. Avidan AY, et al. Among authors: jaros mj. CNS Drugs. 2016 Apr;30(4):305-16. doi: 10.1007/s40263-016-0329-4. CNS Drugs. 2016. PMID: 27067343 Clinical Trial.

5

The Effect of Gabapentin Enacarbil on Pain Associated with Moderate-to-Severe Primary Restless Legs Syndrome in Adults: Pooled Analyses from Three Randomized Controlled Trials.

Hermanowicz N, Ellenbogen A, Irving G, Buchfuhrer M, Jaros MJ, Shang G, Kim R. Hermanowicz N, et al. Among authors: jaros mj. CNS Drugs. 2016 May;30(5):443-54. doi: 10.1007/s40263-016-0333-8. CNS Drugs. 2016. PMID: 27095237

6

Efficacy of gabapentin enacarbil in adult patients with severe primary restless legs syndrome.

Lee DO, Buchfuhrer MJ, Garcia-Borreguero D, Avidan AY, Ahmed M, Hays R, Ondo WG, Jaros MJ, Kim R, Shang G. Lee DO, et al. Among authors: jaros mj. Sleep Med. 2016 Mar;19:50-6. doi: 10.1016/j.sleep.2015.11.002. Epub 2015 Nov 14. Sleep Med. 2016. PMID: 27198947

7

Effect of Gabapentin Enacarbil on Individual Items of the International Restless Legs Study Group Rating Scale and Post-sleep Questionnaire in Adults with Moderate-to-Severe Primary Restless Legs Syndrome: Pooled Analysis of 3 Randomized Trials.

Ahmed M, Hays R, Steven Poceta J, Jaros MJ, Kim R, Shang G. Ahmed M, et al. Among authors: jaros mj. Clin Ther. 2016 Jul;38(7):1726-1737.e1. doi: 10.1016/j.clinthera.2016.05.008. Epub 2016 Jun 7. Clin Ther. 2016. PMID: 27288210

8

Predictors of clinical response in a double-blind placebo controlled crossover trial of gabapentin enacarbil for restless legs syndrome.

Winkelman JW, Jaros MJ. Winkelman JW, et al. Among authors: jaros mj. Sleep Med. 2018 Aug;48:1-7. doi: 10.1016/j.sleep.2018.04.001. Epub 2018 Apr 25. Sleep Med. 2018. PMID: 29807228 Clinical Trial.

9

Efficacy and safety of low-dose SoluMatrix meloxicam in the treatment of osteoarthritis pain: a 12-week, phase 3 study.

Altman R, Hochberg M, Gibofsky A, Jaros M, Young C. Altman R, et al. Curr Med Res Opin. 2015 Dec;31(12):2331-43. doi: 10.1185/03007995.2015.1112772. Curr Med Res Opin. 2015. PMID: 26503347 Clinical Trial.

10

NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.

Harrison SA, Rinella ME, Abdelmalek MF, Trotter JF, Paredes AH, Arnold HL, Kugelmas M, Bashir MR, Jaros MJ, Ling L, Rossi SJ, DePaoli AM, Loomba R. Harrison SA, et al. Among authors: jaros mj. Lancet. 2018 Mar 24;391(10126):1174-1185. doi: 10.1016/S0140-6736(18)30474-4. Epub 2018 Mar 5. Lancet. 2018. PMID: 29519502 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

37 results

Search Page